|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:RAF1-PHC3 (FusionGDB2 ID:71827) |
Fusion Gene Summary for RAF1-PHC3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: RAF1-PHC3 | Fusion gene ID: 71827 | Hgene | Tgene | Gene symbol | RAF1 | PHC3 | Gene ID | 6037 | 80012 |
Gene name | ribonuclease A family member 3 | polyhomeotic homolog 3 | |
Synonyms | ECP|RAF1|RNS3 | EDR3|HPH3 | |
Cytomap | 14q11.2 | 3q26.2 | |
Type of gene | protein-coding | protein-coding | |
Description | eosinophil cationic proteinRNase 3cytotoxic ribonucleaseribonuclease 3ribonuclease, RNase A family, 3 | polyhomeotic-like protein 3early development regulator 3early development regulatory protein 3homolog of polyhomeotic 3polyhomeotic like 3 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000251849, ENST00000442415, ENST00000534997, ENST00000542177, | ENST00000467570, ENST00000474275, ENST00000481639, ENST00000497658, ENST00000494943, ENST00000495893, | |
Fusion gene scores | * DoF score | 24 X 15 X 16=5760 | 8 X 7 X 6=336 |
# samples | 28 | 10 | |
** MAII score | log2(28/5760*10)=-4.36257007938471 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/336*10)=-1.74846123300404 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: RAF1 [Title/Abstract] AND PHC3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | RAF1(12641190)-PHC3(169815172), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | RAF1-PHC3 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. RAF1-PHC3 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. RAF1-PHC3 seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. RAF1-PHC3 seems lost the major protein functional domain in Tgene partner, which is a epigenetic factor due to the frame-shifted ORF. RAF1-PHC3 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. RAF1-PHC3 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | RAF1 | GO:0002227 | innate immune response in mucosa | 12860195 |
Hgene | RAF1 | GO:0019731 | antibacterial humoral response | 12860195 |
Hgene | RAF1 | GO:0043152 | induction of bacterial agglutination | 23992292 |
Hgene | RAF1 | GO:0045087 | innate immune response | 23992292 |
Hgene | RAF1 | GO:0050829 | defense response to Gram-negative bacterium | 23992292 |
Hgene | RAF1 | GO:0050830 | defense response to Gram-positive bacterium | 12860195|23992292 |
Hgene | RAF1 | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 12860195 |
Fusion gene breakpoints across RAF1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across PHC3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-HC-8256-01A | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
ChimerDB4 | PRAD | TCGA-HC-8256 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
Top |
Fusion Gene ORF analysis for RAF1-PHC3 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000251849 | ENST00000467570 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000251849 | ENST00000474275 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000251849 | ENST00000481639 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000251849 | ENST00000497658 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000442415 | ENST00000467570 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000442415 | ENST00000474275 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000442415 | ENST00000481639 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000442415 | ENST00000497658 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000534997 | ENST00000467570 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000534997 | ENST00000474275 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000534997 | ENST00000481639 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000534997 | ENST00000497658 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000542177 | ENST00000467570 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000542177 | ENST00000474275 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000542177 | ENST00000481639 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
5CDS-intron | ENST00000542177 | ENST00000497658 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
Frame-shift | ENST00000251849 | ENST00000494943 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
Frame-shift | ENST00000251849 | ENST00000495893 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
Frame-shift | ENST00000442415 | ENST00000494943 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
Frame-shift | ENST00000442415 | ENST00000495893 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
Frame-shift | ENST00000534997 | ENST00000494943 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
Frame-shift | ENST00000542177 | ENST00000494943 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
Frame-shift | ENST00000542177 | ENST00000495893 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
In-frame | ENST00000534997 | ENST00000495893 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000534997 | RAF1 | chr3 | 12641190 | - | ENST00000495893 | PHC3 | chr3 | 169815172 | - | 10401 | 600 | 29 | 754 | 241 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000534997 | ENST00000495893 | RAF1 | chr3 | 12641190 | - | PHC3 | chr3 | 169815172 | - | 0.010632112 | 0.9893679 |
Top |
Fusion Genomic Features for RAF1-PHC3 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for RAF1-PHC3 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:12641190/chr3:169815172) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | RAF1 | chr3:12641190 | chr3:169815172 | ENST00000251849 | - | 10 | 17 | 56_131 | 369 | 649.0 | Domain | RBD |
Hgene | RAF1 | chr3:12641190 | chr3:169815172 | ENST00000442415 | - | 11 | 18 | 56_131 | 389 | 669.0 | Domain | RBD |
Hgene | RAF1 | chr3:12641190 | chr3:169815172 | ENST00000251849 | - | 10 | 17 | 355_363 | 369 | 649.0 | Nucleotide binding | ATP |
Hgene | RAF1 | chr3:12641190 | chr3:169815172 | ENST00000442415 | - | 11 | 18 | 355_363 | 389 | 669.0 | Nucleotide binding | ATP |
Hgene | RAF1 | chr3:12641190 | chr3:169815172 | ENST00000251849 | - | 10 | 17 | 138_184 | 369 | 649.0 | Zinc finger | Phorbol-ester/DAG-type |
Hgene | RAF1 | chr3:12641190 | chr3:169815172 | ENST00000442415 | - | 11 | 18 | 138_184 | 389 | 669.0 | Zinc finger | Phorbol-ester/DAG-type |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000474275 | 0 | 5 | 19_26 | 0 | 187.0 | Compositional bias | Note=Poly-Thr | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000474275 | 0 | 5 | 324_539 | 0 | 187.0 | Compositional bias | Note=Gln-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000474275 | 0 | 5 | 346_670 | 0 | 187.0 | Compositional bias | Note=Pro-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000474275 | 0 | 5 | 89_287 | 0 | 187.0 | Compositional bias | Note=Ser-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000497658 | 0 | 4 | 19_26 | 0 | 152.0 | Compositional bias | Note=Poly-Thr | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000497658 | 0 | 4 | 324_539 | 0 | 152.0 | Compositional bias | Note=Gln-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000497658 | 0 | 4 | 346_670 | 0 | 152.0 | Compositional bias | Note=Pro-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000497658 | 0 | 4 | 89_287 | 0 | 152.0 | Compositional bias | Note=Ser-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000474275 | 0 | 5 | 919_983 | 0 | 187.0 | Domain | SAM | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000497658 | 0 | 4 | 919_983 | 0 | 152.0 | Domain | SAM | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000474275 | 0 | 5 | 691_720 | 0 | 187.0 | Motif | Note=HD1 | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000497658 | 0 | 4 | 691_720 | 0 | 152.0 | Motif | Note=HD1 | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000474275 | 0 | 5 | 776_810 | 0 | 187.0 | Zinc finger | FCS-type | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000497658 | 0 | 4 | 776_810 | 0 | 152.0 | Zinc finger | FCS-type |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | RAF1 | chr3:12641190 | chr3:169815172 | ENST00000251849 | - | 10 | 17 | 349_609 | 369 | 649.0 | Domain | Protein kinase |
Hgene | RAF1 | chr3:12641190 | chr3:169815172 | ENST00000442415 | - | 11 | 18 | 349_609 | 389 | 669.0 | Domain | Protein kinase |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000494943 | 13 | 15 | 19_26 | 932 | 984.0 | Compositional bias | Note=Poly-Thr | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000494943 | 13 | 15 | 324_539 | 932 | 984.0 | Compositional bias | Note=Gln-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000494943 | 13 | 15 | 346_670 | 932 | 984.0 | Compositional bias | Note=Pro-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000494943 | 13 | 15 | 89_287 | 932 | 984.0 | Compositional bias | Note=Ser-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000495893 | 13 | 15 | 19_26 | 944 | 996.0 | Compositional bias | Note=Poly-Thr | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000495893 | 13 | 15 | 324_539 | 944 | 996.0 | Compositional bias | Note=Gln-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000495893 | 13 | 15 | 346_670 | 944 | 996.0 | Compositional bias | Note=Pro-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000495893 | 13 | 15 | 89_287 | 944 | 996.0 | Compositional bias | Note=Ser-rich | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000494943 | 13 | 15 | 919_983 | 932 | 984.0 | Domain | SAM | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000495893 | 13 | 15 | 919_983 | 944 | 996.0 | Domain | SAM | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000494943 | 13 | 15 | 691_720 | 932 | 984.0 | Motif | Note=HD1 | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000495893 | 13 | 15 | 691_720 | 944 | 996.0 | Motif | Note=HD1 | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000494943 | 13 | 15 | 776_810 | 932 | 984.0 | Zinc finger | FCS-type | |
Tgene | PHC3 | chr3:12641190 | chr3:169815172 | ENST00000495893 | 13 | 15 | 776_810 | 944 | 996.0 | Zinc finger | FCS-type |
Top |
Fusion Gene Sequence for RAF1-PHC3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>71827_71827_1_RAF1-PHC3_RAF1_chr3_12641190_ENST00000534997_PHC3_chr3_169815172_ENST00000495893_length(transcript)=10401nt_BP=600nt CAACACACAACTTTGCTCGGAAGACGTTCCTGAAGCTTGCCTTCTGTGACATCTGTCAGAAATTCCTGCTCAATGGATTTCGATGTCAGA CTTGTGGCTACAAATTTCATGAGCACTGTAGCACCAAAGTACCTACTATGTGTGTGGACTGGAGTAACATCAGACAACTCTTTTCTCAGC ACAGATATTCTACACCTCACGCCTTCACCTTTAACACCTCCAGTCCCTCATCTGAAGGTTCCCTCTCCCAGAGGCAGAGGTCGACATCCA CACCTAATGTCCACATGGTCAGCACCACCCTGCCTGTGGACAGCAGGATGATTGAGGATGCAATTCGAAGTCACAGCGAATCAGCCTCAC CTTCAGCCCTGTCCAGTAGCCCCAACAATCTGAGCCCAACAGGCTGGTCACAGCCGAAAACCCCCGTGCCAGCACAAAGAGAGCGGGCAC CAGTATCTGGGACCCAGGAGAAAAACAAAATTAGGCCTCGTGGACAGAGAGATTCAAGCTATTATTGGGAAATAGAAGCCAGTGAAGTGA TGCTGTCCACTCGGATTGGGTCAGGCTCTTTTGGAACTGTTTATAAGGGTAAATGGCACGGCTGCCAGGATATCGCAGATGAATTCAGAG CACAGGAGATTGATGGACAGGCCCTTCTCTTGCTGAAAGAAGACCATCTCATGAGTGCAATGAATATCAAGCTAGGCCCAGCCCTGAAGA TCTGTGCACGCATCAACTCTCTGAAGGAATCTTAACAGGAACATGAAGCCTTGATAAAACAGCAGTTTTACTTTTCTCACAAAAACTTGT AAGGTAAAGGCCTAACTTGGTCTAGAATATGACACTTATTGTGGTGGATAGCCAAGCACATTGGGATCTCCACATCAAATACTGACATTT CTTCTACAGGTATAATAATTCATCATGCATTTTCATAATTAATAAACATTGGTAAAATTAATTTTACAGGTTACATGAAACATTGAAAGA CTTGTTACAGAGGGCCATGATATTTTTCAAAGAAATGTGTTATACTAGATAATTTTTTTAAAGGTGATGTTTATCATTAATATAAAGAAT CCTTTTAAAAGTAATTTAATGATTTACATTTCTCCTCTTTTGATTCAATTTTCTTATACATTTTTTCTACCCTATTAGTTTTCTAAAGGT TGTCATGAGAGGTATATTATGGAATAATTTAGTAGTCCAGTGACAGAATCGTATGAAATCAGTGTACATTTTAAAAAACATGTCTTTTAG ACATATGCTTTATCTATAAAAAAGGAATTGTGTTCTAGTATGAACAATACTGATCTGGAAGTGAGAAGAGTTAGTTTCTATTCCAAACTT GACCAAGAATTTGGTTTGACTGAGAACGTTTTCCTCTCAGTTTTTGTACATTTATTTAGAGCAGTGGTTCTCAGTGGAGGTCAGTTTTGA TCGCCAGGGGACATCTGGCAATGTTGAGACATTTTGGTTGTCACAGCTTGGGGGTGGGTTCAGGGGAGGGTTGCTACTGGTGTCTAGTAG TTAGAAGCCAGAGATGTTTCTAAACATCTTATAATGCACAGGACAGCACCCCTCCACTGTAAAGAATTATTGGTTCAAAAATATCGGTAC TGCCAAGGTTGAGAAACTCTGATATAGAAGGAGTGATAAATATTGTTTTCACCCAAAGGAATACTTTTAAAGGATGAAGCTTACTAAACA TATATGATGGAAGTATTATTCAGATAACATTAATATTCTGCTGAATAATTTTTTCTAGTTTAATCATACTAGAAAAAGAAAAAAAATCTA CAAATTGTCCTATAAAATAAGGACAAACATGCAAATAATTTAACTCTCAGAAAGTACTAATTCATTCTGATTATCTTTCATACCTCTGTG CTCCTCTGCACTGACGAAGACATAATATGATTATACCTATGAACTAGTGCACAGCCTTTTCTGGCAAGAAAATAGTTTGTAGCAGATACG TGGTTGCTCTTTGGATTTTTTTCTATTGTTGAACATGCTGGGACTAGCTAGAATGCACATTCCTACTTCCTTTACCAAACGTTTGCATGC TTCCTGCAAAGCACTTACCAAGTGATTTCTCTTGAACCATCGGATATAATTTTGTATGTACATGTTTGAGGAAAAAAATGTAAAGCAAAA CCTTTTACTGAACAGTGTTCTATAGAATTATGACACTAAAACAAAATTGTTTGTGGAAGCCCTGAAAGCTTTATAGTCCTGGACATCAAA AATTTTATTTGAGATGATGAATGTTTTGTTTTCATCTTTTCTTATATTACCACAATTGAGATATTTTAGTAATTGAAGGAACATACACAG ATATTTGGCAGAAGTCGAGTAAGGAGGGGAAAAAAAGAGTCCGTGAGTTTCAGTCATTTTCACTGCTCTTTTCAAAAAGATTGTGTTGAG CTGGTAGAAGACTAAAGATGTCACTGAAGACATCACAGATACTATATTTATCTTTTGGCTTTGTGTACATTAGAGAATGTTGATTATTTT TATACAAAAATACAGCGGGTAATTTTTTTAATCTTTAGATGCCTCTTGTTTGAATGTATGCTTTGTGGAATTCTTTGTGTAGTAATGTTT TAAAAAAAGATGTTTACTGATAGTTACATGTAGGATTAGAATATGTAATATAATATAAGGCTCATGTTCCAGACCTACGATAGCTTGTAG TCTATGTTACGTATTTCTTTATATCACATTTTTAATCATTGGATTAAAGTATCAAGGAAAGCTAGGTACTCTATAATGAGTTTTCATTTA TTAGCAGTTAATCATCATGACAGAATTGTCATATGCTTGACTTTTCCCTCTTCTTGGAATTTCAGAACACAAATACAGGCTAAGCATTAG TAAGAGATGGCCCACAGTATGAGAGAGAGAGGTGCAACGGAAAATCTCGCCTGGAATTAAAACTTTTCATAGATTATCCACGGTTAATAC AAAATTTATTATATGGGGATAGACTGCTCCAGCAATAATGATTACATCCTATAACTGTATTACCTATGGCCTTTAAGGTATCAATTTTGA ACTGTGTTGTAGGCTCTCCTTTTATTTGTTCTCTTTCCTAATAGCAGCCATTCTGTACTTATTGAAAGCCCCTGTGCCTACTGCTGTCTT AAGTATTCAGGAGGGGCTTACAAGAGGGTTTTCTATTGGAGAATACCGTATAATCTTAAATCTAGTCCAGATCTCTGTTGTCCCCACTCA AAACATACACAAAATATGCACTTGCTTTTTTCAAGTGAGTTTTTATTTAAAAATGGCTTGTTTGCTATCACATTGGTGCAGCTGTTTCTT TCAAGATGAGTTAATCATCTTAATTTCAAAGCTTCAGCTATATATAATGGATATATAGACAACACTGAGCATCCACCTCTCTCCTGAGCT TTAAAGCAGAGTTTCAGTATGATATAGGTGGGGAGAGTAAATTGTTTTCATATCCTTTCATACTACTACTAATAGTTTTAGGATTTTGAC TGGGGAGAGATAATGACAAACAGAAAGGGAACATGGAGGTTCTTCCTACTTTTGCTACCTAAGTTTGCATTTTCTGACTTCCTTGCAGTG TTGCACTCTTTGTCCCATTGGGATAAAAAGCATAAGTTTGAAATTTTGCTTTAAGCCTTGTGTTCCTGGGGAAGTTAAACAACTAAGAGA GCTGATTTGTAAAAATTATTTTTTATATGACATTAATATTCATCAAGCCTTGTGTAGGCATGTGTAAGACACAGCTATGCAGCTTTGAGT AGTCAATATAGTATGAGATAGAGTGTTGTCCCAAATCCTCCTGTCACTTTTTAAGTAGCATATTATTTCCCTGATGGTCCTGTTACTTTG CTGTTGAATGCTCTAAACAGAACTTTTTAAAAGGTGTGTTTTAAGAGCAGTCACCTAGGAGTAGACAAGGTGGAATGGGAGGAGAGAAAT GGTAATGCAAAAGCTTGAGCATGGGAAGAGTCAGAGGAGGAGGCCATCATCCTTGTTAGCTTAGCCTACTTCAACACTGAGCACATTTCT GCACTTTTGAAGTGAAATTCATGTTTTACTTAGAAGAAATAATTTTCTTTCATTAGGGATCCCAGTTGATTTTTGTTTCCTGGTGTATCA AAATACTTAGAACTATGAAACAAGTATTATTGTGATCATGCCTTTGAATAATTTTTGACGTAGCTTATCTTCATGTATCAAGTATAAAAT TATAATGAGACATCTATTCACAAATACAAGTCTTAGATTGAATTGAAATGTGTTATAGTGCCCTGTCTCCCACTGACTTGTTCAGTTAAA TGTCTTAAAGTACATTATGTACATCTTCAGGCTTTTGGTACCACAATGGCACAAGTATGGTAGGGAGGCAATATAGTCTTAGGCTATATG CCTATATTAAGTGTGTATAAACAATTTTTGAAAGAATACACTATTATAGATGTATGTGAGTGATGCTGACCTGACAGCCATATCCAGTGG ATGAAACTGACTGGACACACTGTTAAAATGTTTTAAAGATGTATTTTCAGCCAGAACAGCCTGGTTATAGTTTGTGGTTTTCACCTTGGT GGATTGCAGGAACACATGCAGCCTACTGGCATTGAGCATTAGCTAATGGCATGAAAGGGCCTCATCTCACTACCTCTCTAAGGCCTCTAG CTCCAAGAAAACCATGAAAACTTCTTTCTTGGAGAGATCTTTGTCTCAGAATCCTTAGAGAGGATTTCGTATGGGGGCTAACTTTAGGAA GGGAGGCAGCTGGGGCAGGACTTTCTGATACCTGACAGTCATGTTCCAGAGCAACCTTTGGGCAGTGGAAACTGGCGCATCTATGCAAAA TGATTGCTCAATCTCTATCTTGTGTACTACATATGTAACTAGCTGGGCCCTAAGGAAGGTTTTCTAGGGGGAAGGATAGGGAAGTAGAGG AGGAGACAAGTAGGAGGAACAAAGCATTCTAGACCCAAGAGGATAGAAGATATTTAGGATAGATATGGCTTTCATCCATAGTTCAAAATA ATGCGTTTTGTTAGATGCCAGTTATAGCAGTAAATAGGTTATAGTTTTTATATGTCAAGATTTACCTGTAATCAGACTCATTCTTTCACT CTCTATACCCACTGTCTCCATGCTTGGGAGCATGGATATTAATAGTTCCAGTGATGTAGAAGTTAGTGATTTTTGATTTCTGAAAAAGGT GAGAACCTTTTATTACAGTTGGAGAATATTTGTCAAAAATTCAAAGGTTGTTGTAATTGAGTTGCCAGAATTACAGAGTTTCCATTTTCA GATATCACAGTTGAATCACCTCTGTAGATTGTTATAAAGAGAGGCATTTTAAGATAGTATTTTATTTGCTAGGTTGTGTCTCAGTCTAAG AATTGGGAAAAGAAGAGCTATAGGTTTCTCTTTCCTAGTCTGGATTTCAGTAAACACAAGCCTACCTCTGCTTCTTTGGTTCACAGCAGT GTGGATCATGAAATGAACTGTTTACCCACATTCATCAATATTGGTATTTTACAAATCTACTTGGAGCATTTAATTTCATCTCAAAGATTG TGATCCACTTTAGATAAGCACAAATACAGTATTAGGAAAAGTAAATATGCAATCTTACTAAAATTTCAACTTGTTAAGCTGTATATCTTA AAAGAAATTATTTGGGGCTGGGCATGGTGGCTCACACCTGTAATCCCAGCACTTTGGGAGGCTGAGGTGGGTAGATCACCTGAGGTCAGG AGTTCGAGACCAGCCTGACCAATATGGTGAAACCCTATCTCTACTAAAAACACAAAAATTAGCTGGGTGTGGTGGCATGCACCTGTAATT CCAGCTACTTGGGAGGCTGAGACAGGAGAATTGCTTGAACCCAGGTGGTGGAGGTTGCAGTGAGCCAAGATCACACCCCTGCACTCCAGC CTGGGTGACAGAGCGAGACTCCATCTCAAAAAAACAAAACAAAAAATTATTTGGGAAGATACGTCCTCTTTTATTAGAAGTTCATAAAAT GTATCATATAGTTTTGTTCACAGTAGTTATATAAGCTTTCTTCAAATAAATTTAAAATTAGATTACCTTCTTTGGAAAAAGAATTTCCTA AATTTTTAAGAATTTTCAAAGTTTTACATATTAGTTTTTAGAACCTAATCCGTTTTAAAATTGTACTATGAGAAAGCTTTTTTTTGAAAG TTGTAAAGCATTAATACAAATAATACAAATATAATTATTACCATCACATTCCAGAGAATATGGCTTTTTCTAAACTTTCAATTTAGAAAA CATACATTAAGGGAGAATCTCTGCCCTCCTTTTCAGCTCTGAAGATCAGCTTTTCTACTCAGACACATGCACACACCCCTTCCAAGTGTC ATGTTTATGGGAACATTTGGGAAATGTTTTCCAGATGTTTTATTTTTTCCCTTTTATAGTTTGTTGACATTTAATTTTACTTAAAGATGA CAATTTTAATCGGAAATGTTAGAGGTACAACATAGTGAGGTTCTAGCTAGCTTTATACTTTTGAAAAATATTTTTGTTTCTACTGCTTTT TACAAGTACTAGTCCTCTCAGTGATACTGGTGGTGTTCAGTATGAATCCATAGAAAGAAAACAAAATTTGTTGTTTAAAAAAAGCAGAGT AATGAATGAATTTCAGTTTTGAAAACAACATAATTTGAAAACACTGTTATACTAACATGGCAAGGTGTTAATTAAATATAAGAGTAAGGT AGTAAGTTCTTTTAGAGCACCTGTTTAAATTTACTCCAGTAATCATCTTAAGGATTGATAGTCACCATCACTTATTGGCTTAAAAGTTAT ATTTCATGGAATATTATCAGTGTTAAATCCAAGCTTTGTGGAGCTTTAAGTGATGGTGGTGAAAAAGTTGGTGTTTATGAGAGAGTGGTG GGGTGTCTAGTCATTAGTGAAGTTAAACATCAACCTGTTTTAGAAAGAATTTTTTAGTCTTGCCTAAAGTAAACCAGAAGTGTCTAGTGT TTAAATCTTTATTTAGAATGCTTCTCTTAAAAGTATTTTTTGTTTTGGGTAGTATTAAATAATCAGTAAATAATCTATTTCAGTAGTAAA TAATGAATTAAGATGATGATGAATGAGGATTAACACACTGGTCTGGAGACTGGGGTTTTATTTCAGTGGGTTAGCTGTGTGTGACATGTT GGGCAATTACTCAGCTGTTTTAACAGCTTCCAGATATGCAGTATGGTGCCTGTACTACTCAAAAGTTGATTTTGGTTTAATTCATCTTTA AGGTACCTCCCAGCTCTAAAACTATGATTCTAGGCTGTGTAATGGGGTTATTCCTACTTTATTCTCTTTCCTTTTTTAAGGGTTCATTTT ATACTTAATAAGCATCCATTTCTTGGGTCACCTACAGTCTTTGTTCTCCTAAGGATTAAAATAGAAAATTCATACATAACAAGCAAATGA TGACATTTTCCTAAATGCTCCTTATTGGTTAACCACTGAATATATGAACACATATGAATATTGTCATTCATGTACTTAAATTCATTTAGC AAACTATTTGAACACTTACATGTGCAGTGTTTGGTGAACATGACATGAGGAACTAGTAGTAAGTAAAATCTTCCCCCCAAAATTCATTGT GGCTTAAATAAATATGAACATAATCATTACTACTTAATATACTGAGAGGGAATCTTAATAAACTTGGAACTGGGAGGGAATATTTGTATA CATTGGGTAAAGGGTTAGGCTAGATGACATCTAAGGGGTCTGAGTGAATCATATCATAATTTTTATAACACATTTCACATACTAAACATC AGTTGGCCCCATACCTGATTAAGTTACAAAATTTAGGAGACTTAACATTAAGGACTTACAGGTTGAGACAGCCCGTATTTCACAACATTA TTTTGACACTTGACTCTATTCCAGAGTTGTTGCTATACAAGGCATGTGGCAGAACAAAAAAAAAGCTGGTGTTGATATAAGAGCTTTTTA CCCAGTATTGACAGTGAGCAACTTTCTTTCTTTTTTTTTTTTTTTCTTTTTTTTTTTTTTGAGATGGGTTCGCTCTGTTGCCCAGGCTGG TGTGCAGTGGTGCGATCTCAGCTCACTGCAACCTCCACCTCCCGGGTTGAAGCGATTGTCTTGCCTCAGCCTTCCAAGTAGCTGGAATTA CAGGTGCCCGCCGCCACACCTGGCTAATTTTTGTATTTTTAGTAGAGACGGGGCTTCACCATGTTGGCCAGGCTAGTCTCGAACTCTTGA CCTCAAGTGATCCACCTGCCTTGGCCTCCCTAAGTGCTGGGATTACAGGCATGAGCCACCACACCTGTCCGACAGTGTAGCAACTTTCTA AAACTGAAAAATCTCAAAGGAGATCATTGGAACTGACTTGTTCATTTATTTTTTGTTTTTAAATTAAGAAAGATTACACAAAATAAGTGT TACTGTACTTTAAGCTATTACAAATATCCAACTTTTAAAGATATGTAAGAATCAGTAATATTCTAGAAAGCACATATATAGTAAAAGGGC ATCCTTTAAATGTAGAACGGGTAAACATGAAACAGTTCCATGCTTGAATTGTTAAGTATCTAGGGGGTAAACATTGAATGGGAGAATCAT TTATTGGGTTAAGGTCCCTTCCTTGTCATTCTGGGATCTGTGAATCACATTGTAATTCCTGTTGACAAAGCTTTACTTGTTAACATCAGT TGATACTGACATTCTCCATAAAGATATAGAATGAAAATATCTATTAAAAATAGTTTATCATTGTTTTAGCTTTTTTGTTTTGTTTGTTTT GAGACAGAGTCTCACTGTCACCCAGGCTTGAGTGCAGCGGTGTGATCTTGGCTCAATGCAACCTCCACCTCCCAGGTTCAATAGATTCTC CCACCTTGGCCTCCCAAGTAGCTGGGATTACTGGCATGCACCACTATGCCTGGCCAGTTTTTTGTATTTTTAGTAGAGATGGGGTTTCAC CATGTTGGCCAGGCTGGACTCGAACTCCTGACCTCAAGTGATCCGCCCACCTCAGCCTCCCAAAGTGCCGGGATTATAGGCATGAGCCAC TGCGCCTAGCCTGTTGCAGCTTTTTAAAGCAGGAAAATATCCATATAAACTGTTGGGTTAGAATCTATATTAGAATCTTTCAAACTAATT GAAAACAGGAAGACTATCATCTAAGTAGCCAGATAATCTGGGTTTCAAAAAGTTATTCCATGGTACTGGTTTAAAAAATACTTTTCAAGT GTTTTAATTTTTAAAGTGTAACTAATTCTTCAAATATGTTATGCTGTTAAAATATGTATTCCATAAGTACTTTTTGTATATGTATTCTTA AATTTTAAAAAGTCAACTGAATGCGCAAAGATGATATAATTTTGGATGTAGACATTTAAACTAGATTCCCAGTCCTCTCCTTCAAAAGCT TGGTCTTTGTTTTTCCTATAGGGAAAAAAGTCAAAATAAGTTCCAAAAACTATCCTCAAAGTAGTATTGTGCTTGTAGTAAATGAAGGTT GGATGGATGGATACTGACAATGGTGGCAGGCATTTCAAGCCTTTTAAATTAGTACTTTTTGTCGTCTTGCTTATTAAAATTTTGTTAATT TTAGCAAAGACCAATTGTTGTGATAAACTGGTGTTTTTTGGATGCTTCAAGCACACGTTAACCAATTTTTTAATTCCCCTTTTGGTTCCT CCCATTGTTCTAAAATAGGACTTTCATATTATTAAAACCTCAAAAGATGATCCACCCAGGATGAACAAAGATCACCAAGGGGAAAGAAAA CATTTTTTATCTTTACAGAAAACATGTTAAGATTATATATAGATGTATTCTTTACATTGGATATTGTATTAGAGTCCTCCTTACAAGAAA TGAAATAGTTTTTAGCACTCTTAGCATTAGAGTTCCTAGATTGGTGTTGATAGCTACAGTTTTAAAATGTATAACCTGAAAATGAAGGTT AATTTTGCATTGTAAGAGCACATTTGATCTATGTAAAAAGTGTCCATTTGGTGTATTTTTTTAAAAAAGAGAAAGCACTTTCATATTAAG TAGCATGTGTATGAATTTAGATTTTCATATTTGTTGTGTCTGTATTCAGTGAAGTAAATTGAGCATTTAAATGTTTGTTGATGGCAACAT TAACTATTAAATTAAAGCACCTTATACTCTGCTGCTTAACTTGCTTGTAATTGCACCTTTGTTACCTGCACATTTTCATATAGAATATTG TTGTAACATTGCTTCATGTGGGTCTGGATGGAAGATTAGTGGGCCTACAGGATCATTTATTTATATTGTTTATATTACAATAATATATTG >71827_71827_1_RAF1-PHC3_RAF1_chr3_12641190_ENST00000534997_PHC3_chr3_169815172_ENST00000495893_length(amino acids)=241AA_BP=190 MKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLFSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTT LPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGS -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for RAF1-PHC3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Hgene | RAF1 | chr3:12641190 | chr3:169815172 | ENST00000251849 | - | 10 | 17 | 331_349 | 369.3333333333333 | 649.0 | PEBP1/RKIP |
Hgene | RAF1 | chr3:12641190 | chr3:169815172 | ENST00000442415 | - | 11 | 18 | 331_349 | 389.3333333333333 | 669.0 | PEBP1/RKIP |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for RAF1-PHC3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for RAF1-PHC3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |